Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478848 · ClinicalTrials.gov registry record · Phase 1
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
A Phase 1 study, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT07478848 is a Phase 1 study that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 14 participants.
The verdict
NCT07478848, a Phase 1 study, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas
Interventions
- RADIATION Radiation Therapy
- BIOLOGICAL CAR-T
- DRUG Vancomycin 125mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2026-05-29 |
| Est. Completion | 2029-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07478848
The ClinicalTrials.gov registry entry for NCT07478848 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Radiation Therapy is the first listed.
NCT07478848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07478848 about?
NCT07478848 is a clinical study titled "Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas". This clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas
What is the current status of trial NCT07478848?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2026-05-29. Estimated completion is 2029-01-01.
What interventions are being tested in trial NCT07478848?
The interventions under investigation include: Radiation Therapy (RADIATION), CAR-T (BIOLOGICAL), Vancomycin 125mg (DRUG).
Who is sponsoring clinical trial NCT07478848?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.